AAREYDRUGS

Aarey Drugs & Pharmaceuticals Share PriceAarey Drugs & Pharmaceuticals

₹23.45
-0.9 (-3.7%)
As on 26 March, 2023 | 17:07 BSE: 524412 NSE: AAREYDRUGS

Aarey Drugs & Pharmaceuticals Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Aarey Drugs & Pharmaceuticals

Start SIP

Aarey Drugs & Pharmaceuticals Share Price

  • Over 1 Month -20.1%
  • Over 3 Month -43.22%
  • Over 6 Month -40.86%
  • Over 1 Year -45.15%

Aarey Drugs & Pharmaceuticals Key Statistics

P/E Ratio 14.7
PEG Ratio -0.3
Market Cap Cr 60
Price to Book Ratio 0.5
EPS 2.6
Dividend 0
Relative Strength Index 26.17
Money Flow Index 22.73
MACD Signal -1.8
Average True Range 1.6

Aarey Drugs & Pharmaceuticals Investment Rating

  • Master Rating:
  • Aarey Drugs & Pharms. has an operating revenue of Rs. 376.32 Cr. on a trailing 12-month basis. An annual revenue growth of 39% is outstanding, Pre-tax margin of 2% needs improvement, ROE of 5% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 27 which is a POOR score indicating inconsistency in earnings, a RS Rating of 5 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 91 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Aarey Drugs & Pharmaceuticals Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 6276117120
Operating Expenses Qtr Cr 6172118118
Operating Profit Qtr Cr 24-12
Depreciation Qtr Cr 1000
Interest Qtr Cr 1111
Tax Qtr Cr 0002
Net Profit Qtr Cr 0310

Aarey Drugs & Pharmaceuticals Technicals

EMA & SMA

Current Price
₹23.45
-0.9 (-3.7%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • 27.02
  • 50 Day
  • 30.33
  • 100 Day
  • 33.11
  • 200 Day
  • 35.4
  • 20 Day
  • 27.13
  • 50 Day
  • 31.26
  • 100 Day
  • 34.72
  • 200 Day
  • 35.69

Aarey Drugs & Pharmaceuticals Resistance and Support

PIVOT
₹24.77
Resistance
First Resistance 25.29
Second Resistance 26.22
Third Resistance 26.74
RSI 26.17
MFI 22.73
MACD Single Line -1.8
MACD -1.98
Support
First Resistance 23.84
Second Resistance 23.32
Third Resistance 22.39

Aarey Drugs & Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 72,630 4,478,366 61.66
Week 86,229 5,140,985 59.62
1 Month 47,036 2,788,274 59.28
6 Month 62,285 3,455,583 55.48

Aarey Drugs & Pharmaceuticals Result Highlights

Aarey Drugs & Pharmaceuticals Synopsis

NSE-Medical-Diversified

Aarey Drugs & Ph is involved in the business activities of Activities of commission agents dealing in wholesale trade inwood, paper, skin, leather and fur, fuel, petroleum products, chemicals, perfumery and cosmetics, glass, minerals, ores and metals. Company’s Total Operating Revenue is Rs. 492.68 Cr. and Equity Capital is Rs. 25.38 Cr. for the Year ended 31/03/2022. Aarey Drugs & Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 15/05/1990 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1990PLC056538 and registration number is 056538.
Market Cap 60
Sales 376
Shares in Float 1.27
No of funds 2
Yield 0.44
Book Value 0.52
U/D Vol ratio 0.5
LTDebt / Equity
Alpha -0.14
Beta 0.96

Aarey Drugs & Pharmaceuticals

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 50.03%50.03%50.03%
Foreign Portfolio Investors 3.92%3.98%3.92%
Individual Investors 42.41%42.25%42.48%
Others 3.64%3.74%3.57%

Aarey Drugs & Pharmaceuticals Management

Name Designation
Mr. Mihir R Ghatalia Chairman & Managing Director
Mr. Nimit Rajesh Ghatalia Executive Director
Ms. Archana Pramod Wani Woman Director
Mr. Lalit Radhakrishna Tulsiani Independent Director
Mr. Anil Mandal Independent Director
Mr. Chetan K Mehta Independent Director

Aarey Drugs & Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Aarey Drugs & Pharmaceuticals FAQs

What is Share Price of Aarey Drugs & Pharmaceuticals ?

Aarey Drugs & Pharmaceuticals share price is ₹23 As on 26 March, 2023 | 16:53

What is the Market Cap of Aarey Drugs & Pharmaceuticals ?

The Market Cap of Aarey Drugs & Pharmaceuticals is ₹59.5 Cr As on 26 March, 2023 | 16:53

What is the P/E ratio of Aarey Drugs & Pharmaceuticals ?

The P/E ratio of Aarey Drugs & Pharmaceuticals is 14.7 As on 26 March, 2023 | 16:53

What is the PB ratio of Aarey Drugs & Pharmaceuticals ?

The PB ratio of Aarey Drugs & Pharmaceuticals is 0.5 As on 26 March, 2023 | 16:53

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number